HURRICANE CAPITAL ADVISORS LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
HURRICANE CAPITAL ADVISORS LLC's BMY Position: Q2 2026 in Review
HURRICANE CAPITAL ADVISORS LLC increased its Bristol-Myers Squibb (BMY) stake by 4.7% in Q2 2026, buying an estimated $10.9K and bringing the position to 4,200 shares worth $242K. The position accounts for 0.06% of the portfolio, ranked #313.
HURRICANE CAPITAL ADVISORS LLC first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $604K in Q1 2025. 2,541 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- HURRICANE CAPITAL ADVISORS LLC held 4,200 shares of Bristol-Myers Squibb worth $242K as of Q2 2026.
- HURRICANE CAPITAL ADVISORS LLC bought 190 Bristol-Myers Squibb shares in Q2 2026, an estimated $10.9K.
- Bristol-Myers Squibb made up 0.06% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #313 holding.
- HURRICANE CAPITAL ADVISORS LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- HURRICANE CAPITAL ADVISORS LLC's Bristol-Myers Squibb position peaked at $604K in Q1 2025.
- 2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.